about
The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women.HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.The effect of Arthrospira platensis capsules on CD4 T-cells and antioxidative capacity in a randomized pilot study of adult women infected with human immunodeficiency virus not under HAART in Yaoundé, Cameroon.Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon.Evaluating the performance of a rapid antigen test for the detection of influenza virus in clinical specimens from children in Cameroon.Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon.Different factors associated with loss to follow-up of infants born to HIV-infected or uninfected mothers: observations from the ANRS 12140-PEDIACAM study in Cameroon.Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection.Molecular characterization of a new mosaic Simian Immunodeficiency Virus in a naturally infected tantalus monkey (Chlorocebus tantalus) from Cameroon: a challenge to the virus-host co-evolution of SIVagm in African green monkeys.Simian immunodeficiency virus infection in wild-caught chimpanzees from cameroon.Specific stimulation of HIV-1 replication in human placental trophoblasts by an antigen of Plasmodium falciparum.Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants: Evaluation After Two Years of Treatment in the Pediacam Study, Cameroon.HIV Drug Resistance Testing in a Resource Limited Setting with high Viral Diversity: The first Twenty Eight Months Experience.First evidence of transmission of an HIV-1 M/O intergroup recombinant virus.Feasibility of Routinely Offering Early Combined Antiretroviral Therapy to HIV-infected Infants in a Resource-limited Country: The ANRS-PediaCAM Study in Cameroon.Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.Detection of cytomegalovirus DNA on dried blood spots collected from infants infected with HIV: an in-house method adaptable in resource-limited settings.Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon.Simian T cell leukaemia virus type I subtype B in a wild-caught gorilla (Gorilla gorilla gorilla) and chimpanzee (Pan troglodytes vellerosus) from Cameroon.A natural CCL5/RANTES variant antagonist for CCR1 and CCR3.Characterization of a New HIV-1 Group N Isolate Originating from a Cameroonian Patient.Plasmodium falciparum and placental cytokine profiles among pregnant women in relation to their HIV-1 status: possible implications for mother-to-child transmission (MTCT) of HIV-1 in CameroonPrevalence of HIV-1 drug resistance mutations in antiretroviral naïve pregnant women from Cambodia, Cameroon, Central African Republic and VietnamA Plasmodium falciparum antigen increases HIV-1 replication in a human placenta-derived cell lineWhy do HIV negative mothers refuse to participate in a clinical research involving HIV positive mothers in Cameroon?Perinatal transmission of Cytomegalovirus (CMV) in children born to HIV positive and negative women in Cameroon
P50
Q30377499-8540C08B-298A-459F-AD70-41C5418446A7Q30940547-9531A2D9-BFA4-4507-81E5-CB8CFB013CE4Q33308717-200E032E-CB46-478D-A4AC-0A65BA2AA5FDQ33818426-CB6B1D65-15CF-4AD1-BCF8-F2E35B7A2FD8Q33963346-CE6CE502-7B35-490C-AC05-265BBED908C0Q33982980-CBC26855-574C-42F4-8F83-1BF57B7C1FA2Q34292635-D0DBF5C5-32F6-4232-BE29-C3DB4A75A3AAQ35140240-19ED0944-CE7D-4286-9425-EA8A4FFE8934Q35174331-251E216F-64D6-4053-8CDF-9581C811DE4EQ35782466-40F62E67-2E70-4447-BD4E-4FACDDD3A035Q35807096-A3BB16D5-85CB-44A5-9ADF-274E58DEBCAAQ36376372-A2BF030C-93FB-4C83-A7C8-769AC7476577Q37743348-DFB32720-E7F7-434E-A562-ACB4B04580B9Q39999917-E3CB2294-3D96-47BF-99A2-BCEA8DF719D7Q40070361-EADC0562-A021-4BD5-AD42-517CBD6A7681Q40108038-6DBFDCB1-E17C-40CD-A7F2-4F080E1041AEQ40144635-0FA8FC17-91D3-4AC1-8301-5DDAC25520E5Q41134739-DD54E80E-5B69-428C-9A4C-6D627A356A4EQ42248811-B2CCB843-A471-4AF9-8383-818431D563EEQ42280986-1F33EBC4-DBAA-4EC4-B698-B9C11A9424E2Q43273321-011813CC-DB73-4703-B573-2563C5629C64Q44644328-9AEF0C27-ABA1-4177-938E-9D346B8DDA80Q45699718-DA6F9AF3-964E-4E7A-B6F1-A02B38CD4EAEQ48086566-B387E797-A251-466D-A27B-34CAF14FF0DDQ52633125-58D93DC2-9EFD-4D00-AA0C-FEE77F76631CQ59215721-CD5F9305-3060-4C5D-82CD-7A12566D836EQ59215794-C17D35AD-D5DE-4F6C-966E-0DD46AE51DD2Q59215832-1E0C3C79-9224-4F5E-AAAA-7902F0A903C3Q59248429-3BE0ACBF-CDE4-4BF7-896E-9235D51BB955Q59248435-B3948F16-4D40-4E23-8EC1-A8F1BD19B686
P50
name
Anfumbom Kfutwah
@ast
Anfumbom Kfutwah
@en
Anfumbom Kfutwah
@es
Anfumbom Kfutwah
@nl
type
label
Anfumbom Kfutwah
@ast
Anfumbom Kfutwah
@en
Anfumbom Kfutwah
@es
Anfumbom Kfutwah
@nl
prefLabel
Anfumbom Kfutwah
@ast
Anfumbom Kfutwah
@en
Anfumbom Kfutwah
@es
Anfumbom Kfutwah
@nl